Nevirapine

Product NDC
31722-505
11-digit product format
317220505
Labeler code
31722
Product ID
31722-505_e5515515-0ee0-e288-e053-2995a90a3d7c
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Nevirapine
Dosage form
TABLET
Route
ORAL
Labeler
Camber Pharmaceuticals, Inc.
Application
ANDA078584
Marketing category
ANDA
Marketing start
2012-05-23
Substance
NEVIRAPINE
Active strength
200 mg/1
Pharmacologic classes
Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
Nevirapine
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
NEVIRAPINE200 mg/1

Harmonized Identifiers#

Field, Values table
FieldValues
Unii99DK7FVK1H
Rxcui199422

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
a1bab0e5-3c0a-775a-2f29-a19e4e281871Product name320190610
d07e0b9e-e041-41dc-942a-a2a6601dc221Product name120181029
0d48f664-b8cd-5c4b-aa8e-0a00f1c0002dProduct name820171204

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
31722-505-01Nevirapine100 in 1 BOTTLETABLET10015
31722-505-05Nevirapine500 in 1 BOTTLETABLET50015
31722-505-10Nevirapine1000 in 1 BOTTLETABLET100015
31722-505-60Nevirapine60 in 1 BOTTLETABLET6015

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
31722-505-60EA - Each31722-5051f322066-9957-46ec-9a98-11223932e6ee12012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
NEVIRAPINEACTIVE INGREDIENT99DK7FVK1HNEVIRAPINE TABLET [CAMBER PHARMACEUTICALS, INC.]8
NEVIRAPINEACTIVE MOIETY99DK7FVK1HNEVIRAPINE TABLET [CAMBER PHARMACEUTICALS, INC.]8
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UNEVIRAPINE TABLET [CAMBER PHARMACEUTICALS, INC.]8
COLLOIDAL SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4NEVIRAPINE TABLET [CAMBER PHARMACEUTICALS, INC.]8
CROSCARMELLOSE SODIUMINACTIVE INGREDIENTM28OL1HH48NEVIRAPINE TABLET [CAMBER PHARMACEUTICALS, INC.]8
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30NEVIRAPINE TABLET [CAMBER PHARMACEUTICALS, INC.]8
POVIDONEINACTIVE INGREDIENTFZ989GH94ENEVIRAPINE TABLET [CAMBER PHARMACEUTICALS, INC.]8
SODIUM STARCH GLYCOLATE TYPE A POTATOINACTIVE INGREDIENT5856J3G2A2NEVIRAPINE TABLET [CAMBER PHARMACEUTICALS, INC.]8
STARCH, CORNINACTIVE INGREDIENTO8232NY3SJNEVIRAPINE TABLET [CAMBER PHARMACEUTICALS, INC.]8

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
31722-505NEVIRAPINE (NEVIRAPINE) TABLET [CAMBER PHARMACEUTICALS, INC.]15Current NDC, Legacy NDC, 4 package rows20220805_61409678-d2f6-42cd-b03d-b26b11b39641.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
199422nevirapine 200 MG Oral TabletPSN61409678-d2f6-42cd-b03d-b26b11b3964115
199422nevirapine 200 MG Oral TabletSCD61409678-d2f6-42cd-b03d-b26b11b3964115

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
31722-505-0131722050501100 TABLET in 1 BOTTLE (31722-505-01) 100 tablet2012-05-230000-00-00NoNoCurrent
31722-505-0531722050505500 TABLET in 1 BOTTLE (31722-505-05) 500 tablet2012-05-230000-00-00NoNoCurrent
31722-505-10317220505101000 TABLET in 1 BOTTLE (31722-505-10) 1000 tablet2012-05-230000-00-00NoNoCurrent
31722-505-603172205056060 TABLET in 1 BOTTLE (31722-505-60) 60 tablet2012-05-230000-00-00NoNoCurrent